Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:01 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Type of Gonadotropin and Embryo Kinetics of Development
NCT02402192 · IVI Madrid · PHASE4 · terminated · last registry update 2022-08-11 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, IVI Madrid |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against FSHR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2023-07-20Also stopped (withdrawn): AGUNCO Obstetrics and Gynecology Centre, Recombinant FSH (rFSH) (NCT01267604)
- 2022-11-30Also stopped (withdrawn): Assiut University, Letrozole + Menotropins (NCT04193930)
- 2022-06-23Also stopped (terminated): University of British Columbia, a drug against FSHR (NCT02106689)
- 2022-04-29Results posted on the registry: University of California, San Francisco, Low dose hCG plus FSH co-trigger + Standard dose of hCG (NCT02310919)
- 2022-04-07Results posted on the registry: University of Colorado, Denver, Degarelix (GnRH antagonist) + recombinant FSH (NCT02478775)
- 2022-03-04Phase 3 first posted: Bharat Serums and Vaccines Limited, Recombinant Human Follicle Stimulating Hormone 900 IU (66.0 μg) / 1.5mL Solution for Injection in Prefilled Pen (NCT05266924)
- 2022-03-02Phase 3 first posted: Ferring Pharmaceuticals, REKOVELLE (Follitropin Delta) (NCT05263388)
- 2022-02-17Results posted on the registry: El Shatby University Hospital for Obstetrics and Gynecology, Duphaston + Gonadotropin (NCT04537078)
- 2022-02-03Also stopped (withdrawn): Organon and Co, MK-8962 + recFSH (NCT01599494)
- 2021-12-08Phase 3 first posted: Qilu Pharmaceutical Co., Ltd., QL1012 + Gonal-f ® (NCT05149924)
- 2021-08-23Results posted on the registry: University of Miami, Natesto (NCT03203681)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision